Antonio Nunes

Dr. Antonio Nunes

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
FBFrancisca Bastos
Francisca Bastos
APAna Catarina Pinto
Ana Catarina Pinto
ANAntonio Nunes
Antonio Nunes
SSSérgio Simões
Sérgio Simões

18 July 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MBMariana Biscaia-Caleiras
Mariana Biscaia-Caleiras
DLDiana Lopes
Diana Lopes
CHCarolina Henriques
Carolina Henriques
ALAna Sofia Lourenço
Ana Sofia Lourenço
ANAntonio Nunes
Antonio Nunes
SSSérgio Simões
Sérgio Simões

21 July 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ASAriana Amorim Sena
Ariana Amorim Sena
ACAlain Costa
Alain Costa
FBFrancisca Bastos
Francisca Bastos
APAna Catarina Pinto
Ana Catarina Pinto
Carla VitorinoCarla Vitorino
Carla Vitorino
SSSérgio Simões
Sérgio Simões

15 February 2025 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
MBMariana Biscaia-Caleiras
Mariana Biscaia-Caleiras
NFNuno Fonseca
Nuno Fonseca
ALAna Sofia Lourenço
Ana Sofia Lourenço
ANAntonio Nunes
Antonio Nunes
AFAbel Ferreira
Abel Ferreira
SSSérgio Simões
Sérgio Simões

16 November 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
AKAngelos Karlas
Angelos Karlas
ANAntonio Nunes
Antonio Nunes
WDWouter Driessen
Wouter Driessen
ELEvangelos Liapis
Evangelos Liapis
JRJosefine Reber
Josefine Reber
Breast cancer is a complex tumor type involving many biological processes. Most chemotherapeutic agents exert their antitumoral effects by rapid induction of apoptosis. Another main feature of breast cancer is hypoxia, which may drive malignant progression and confer resistance to various forms of therapy. Thus, multi-aspect imaging of both tumor apoptosis and oxygenation in vivo would be of enormous value for the effective evaluation of therapy response. Herein, we demonstrate the capability of a hybrid imaging modality known as multispectral optoacoustic tomography (MSOT) to provide high-resolution, simultaneous imaging of tumor apoptosis and oxygenation, based on both the exogenous contrast of an apoptosis-targeting dye and the endogenous contrast of hemoglobin. MSOT imaging was applied on mice bearing orthotopic 4T1 breast tumors before and following treatment with doxorubicin. Apoptosis was monitored over time by imaging the distribution of xPLORE-APOFL750©, a highly sensitive poly-caspase binding apoptotic probe, within the tumors. Oxygenation was monitored by tracking the distribution of oxy- and deoxygenated hemoglobin within the same tumor areas. Doxorubicin treatment induced an increase in apoptosis-depending optoacoustic signal of xPLORE-APOFL750© at 24 h after treatment. Furthermore, our results showed spatial correspondence between xPLORE-APO750© and deoxygenated hemoglobin. In vivo apoptotic status of the tumor tissue was independently verified by ex vivo fluorescence analysis. Overall, our results provide a rationale for the use of MSOT as an effective tool for simultaneously investigating various aspects of tumor pathophysiology and potential effects of therapeutic regimes based on both endogenous and exogenous molecular contrasts.

7 February 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
ASAriana Amorim Sena
Ariana Amorim Sena
ATAndreia Tabanez
Andreia Tabanez
FBFrancisca Bastos
Francisca Bastos
ACAlain Costa
Alain Costa
ANAntonio Nunes
Antonio Nunes
SSSérgio Simões
Sérgio Simões
Background: Buccal administration offers direct access to systemic circulation, improving drug bioavailability when compared with the conventional oral route. This advantage depends on the formulation’s ability to remain in contact with the buccal mucosa. Attributes such as adhesion and viscosity are suggested to be correlated and contribute to enhanced residence time at the administration site. Methods: Buccal formulations with varying hydroxypropyl cellulose concentrations were prepared. Adhesion, viscosity, and residence time were assessed using a novel combined qualitative and quantitative approach. Drug permeation was evaluated in vitro using a biomimetic membrane and ex vivo using porcine buccal tissue, and it was further enhanced by adding the permeation enhancer benzalkonium chloride. Permeability measurements were integrated with residence time to estimate effective drug delivery. Results: Increasing HPC concentration improved both adhesion and viscosity, with 2% HPCs (F2) showing the strongest effect (45.5 ± 13.7 g), correlating with longer residence time (43.4% drug retained at 2 min vs. ~20% for 0–1% HPC). Although the polymer slightly reduced apparent permeability, when residence time was considered, drug flux increased 1.6-fold compared to the polymer-free formulation (F0), rising from 12.9 × 10−5 cm/min (F0) to 19.4 × 10−5 cm/min (F2) after 2 min. The addition of BKC further enhanced permeation, with apparent permeability increasing 1.5-fold vs. F2 and 2.5-fold vs. F0. Conclusions: Buccal liquid preparations’ efficacy is influenced by residence time and subsequent drug permeation. Residence time benefits from the synergistic effects of adhesion and viscosity, highlighting the importance of experimentally assessing these parameters during the development of oromucosal products.